Biondvax Pharmaceuticals Ltd - ADR
NASDAQ:BVXV
Earnings Announcements
BiondVax Announces Q4 Results
Published: 03/28/2022 11:31 GMT
Biondvax Pharmaceuticals Ltd - ADR (BVXV) - Biondvax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.17
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00
More details on our Analysts Page.